BiomX Inc.
Overview
BiomX Inc. is a clinical-stage microbiome company developing both natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases such as cystic fibrosis, atopic dermatitis, and colorectal cancer. The company's unique platform allows for precise targeting of bacterial pathogens, potentially revolutionizing the treatment of various conditions.
Therapeutic areas
Microbiome TherapyCystic FibrosisAtopic DermatitisColorectal Cancer
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to BiomX Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.